Results 241 to 250 of about 370,662 (286)

Social Drivers of Guideline-Discordant Breast Cancer Screening by Age and Mortality Risk. [PDF]

Cancer Epidemiol Biomarkers Prev
Lui ML, Lee Argov EJ, Kehm RD, Karr AG, Moise N, Shelton RC, Tehranifar P.   +6 more
europepmc   +1 more source

Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)

BJU International, EarlyView.
Objectives To evaluate basal‐luminal cell of origin subtyping using Prediction Analysis of Microarray of 50 genes (PAM50) genomic classification profiles for predicting disease progression in men undergoing active surveillance (AS) for prostate cancer (PCa).
Ankur Malpani, Jonathan T. Ryan, Hui Yu, Nachiketh Soodana‐Prakash, Archan Khandekar, Tarek Ajami, Adam Williams, Zoe Szczotka, Mohammed Alshalalfa, Yangyang Hao, Elai Davicioni, Sanjaya Swain, Oleksandr Kryvenko, Alan Dal Pra, Radka Stoyanova, Sandra Gaston, Alan Pollack, Brandon A. Mahal, Matthew Abramowitz, Bruno Nahar, Chad R. Ritch, Bruce Kava, Mark L. Gonzalgo, Dipen J. Parekh, Sanoj Punnen   +24 more
wiley   +1 more source

Repurposing of the Macrolide Antibiotic Clarithromycin for the Prevention of Lung Cancer. [PDF]

Mol Cancer Ther
Deng S, Hussain T, Bartelli TF, Sebastian MM, Zarghooni M, Velasco WV, Somerville B, Phan L, Savage MI, Song Y, Clifford JL, Kadara H, McAllister F, Brown PH, Moghaddam SJ, Aldaz CM.   +15 more
europepmc   +1 more source

Phase I Study of Mogamulizumab in Combination with Pembrolizumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma-A National Cancer Institute Experimental Therapeutics Clinical Trials Network (NCI-ETCTN) Trial. [PDF]

Cancers (Basel)
Joffe E, Kumar A, Tuscano JM, Moskowitz AJ, Owens C, Noy A, Palomba ML, Zelenetz AD, Ni A, Sharon E, Vardhana S.   +10 more
europepmc   +1 more source

NIH/NCI Consensus Development Meeting on breast cancer screening. Response of the National Cancer Institute.

The Yale journal of biology and medicine, 1978
openaire   +1 more source

Validation of TypeSeq2, a Next-Generation-Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica Laboratories. [PDF]

J Infect Dis
Sierra MS, Coto C, Porras C, Herrero R, Ugalde D, Sauer AN, Mora D, Montes CP, Schussler J, Hoffman AC, Hicks B, Ruggieri D, Cortes B, Hildesheim A, Kreimer AR, Wentzensen N, Dagnall C, Liu D.   +17 more
europepmc   +1 more source

Survey of MaineHealth Cancer Care Network Providers on Cannabis Use: Preparation for Studies Sponsored by the National Cancer Institute. [PDF]

J Maine Med Cent
Prescott JM, Saunders JG, Bradford LS, Remick SC.   +3 more
europepmc   +1 more source

Corrigendum to < 'Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells'> <[Non-coding RNA Research vol. 13 (2025) 153-161]>. [PDF]

Noncoding RNA Res
Rambaldelli G, Asghar S, Venturi G, Zacchini F, Serra M, Giovannini C, Gramantieri L, Bernini M, Inga A, Dassi E, Montanaro L.   +10 more
europepmc   +1 more source

SUBDUE‐3: SUB‐urothelial DUrvalumab‐89zirconium injEction; a phase 0 biodistribution study protocol

BJU International, EarlyView.
Kevin G. Keane, Richard Gauci, Roslyn J. Francis, Andrew M. Scott, Cynthia Hawks, Andrisha‐Jade Inderjeeth, Ian D. Davis, Jayne Lim, Andrew Redfern, Dickon Hayne   +9 more
wiley   +1 more source